Health officials have now identified two more drugs that may be linked to the recent outbreak of fungal meningitis.
All
meningitis cases
were
previously tied to methylprednisolone acetate — a steroid injection
used as treatment for back pain. Two additional cases of fungal
infections in people's joints were linked with the same drug.

But now, one case of suspected meningitis has been linked to a drug
called triamcinolone acetonide, another type of steroid injection,
according to the Food and Drug Administration.
Both drugs were made by the New England Compounding Center in Framingham, Mass.

In addition, two patients undergoing organ transplants developed
fungal infections
after
surgeries that used a NECC drug. The drug, called cardioplegic
solution, is administered to paralyze the heart during surgery. It is
not clear whether the fungal infections seen in these two patients were
caused by the cardioplegic solution, or by something else, the FDA
noted.
So far, the outbreak has affected 214 people in 15 states, and caused
five deaths, according to the Centers for Disease Control and
Prevention.
Patients who received any injectable drug made by NECC — including
drugs used in eye surgery — or who received cardioplegic solution should
be alerted about their potential risk for infection, the FDA says.
Pass it on: Two new drugs, both made by the same pharmacy, have been tied to the fungal meningitis outbreak.